In line with the findings in vitro, cyclocreatine administration could decrease the number of apoptotic neurons, and alleviate cerebral infarction and demyelination, as well as promoting the proportion of IGF1+ microglia, even in Trem2–/– mice (Figure 6H,I). The gene discussed is IGF1; the disease is cerebral infarction.